Aurobindo Pharma has received approval for Tizanidine Hydrochloride capsules
East Windsor, NJ – Aurobindo Pharma has received approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Tizanidine Hydrochloride capsules. Aurobindo’s Tizanidine Hydrochloride capsules are an AB-rated generic that is equivalent to the brand drug Zanaflex® and will be available in 2 mg, 4 mg, and 6 mg dose […]
Aurobindo Pharma has received approval for Tizanidine Hydrochloride capsules Read More »